Lifastuzumab vedotin
Product Specifications
CAS Number
1401812-88-1
Synonyms
LIFA, DNIB0600A, RG-7599
Target
Sodium Channel
Applications
Transmembrane Transporters
Additionnal Information
Lifastuzumab vedotin (LIFA, DNIB0600A, RG-7599) is an antibody-drug conjugate (ADC) composed of a humanized anti-NaPi2b monoclonal antibody and an anti-mitotic cytotoxic agent, monomethyl auristatin E (MMAE) . Lifastuzumab vedotin is used in the treatment of platinum-resistant ovarian cancer.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP303811 20 µg
HLA DMB (HLA-DMB) (NM_002118) Human Recombinant Protein
Sign In for Pricing
View Details 